
Bill Schiffner
Senior Editor at Chain Drug Review
Bill Schiffner has has covered the imaging industry for over 25 years. He is currently a Senior Editor at Chain Drug Review.
Articles
-
1 day ago |
chaindrugreview.com | Bill Schiffner
SOUTHBURY, CT. – From the brand that brought you the beloved Lolleez Organic Throat Soothing Pops for Kids, comes a whole new way for kids to take their vitamins. Meet MULTEEZ, Multivitamin Pops for Kids, the latest innovation from EEZ Co., a bold wellness leader within the space.
-
1 day ago |
chaindrugreview.com | Bill Schiffner
WOONSOCKET, R.I. — Last May, CVS announced the launch of Well Market, a snack line that combines a diverse array of flavors with nutritional benefits to redefine snacking. The snack line consists of more than 200 delicious new snacks, beverages, and groceries in CVS Pharmacy stores nationwide. To make life easier for those on-the-go, these snacks strive to provide an array of innovative flavors and diverse taste perspectives that consumers can feel good about.
-
2 days ago |
chaindrugreview.com | Bill Schiffner
SHELTON, Conn.— BIC, a global leader in shaving innovation for over 50 years, is launching its new BIC Flex 5 Sensitive — a game-changing men's razor designed to tackle sensitive skin with precision and comfort. Clinically proven for sensitive skin, this dermatologist-tested razor features five long lasting blades for an ultra-close, effortless shave—for clearing away those cold-weather beards and other seasonally neglected zones.
-
2 days ago |
chaindrugreview.com | Bill Schiffner
MUSKEGO, Wis.– Jackson's, the snack super brand known for its uncompromising use of avocado oil and real ingredients, announced its entrance into a new snack category with the debut of Jackson's Super Veggie Straws.
-
2 days ago |
chaindrugreview.com | Bill Schiffner
AUSTIN – Embla has announced results from a 64-week real-world study presented at the European Congress on Obesity, tracking nearly 2,700 adults in a digital GLP-1 treatment program. The study found that participants lost an average of 16.7% of their body weight on a mean dose of just 1.08 mg of semaglutide per week, substantially lower than the typical 2.4 mg target used in most U.S. treatment models.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 80
- Tweets
- 125
- DMs Open
- No